Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001415889-24-030005

VP, Clinical Trial Operations acquired 29,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Yu Yong · VP, Clinical Trial Operations

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-18 Grant or award : show line 1 in the form +29,000 39,869 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-18 Grant or award : show line 2 in the form Stock Option (right to buy) +39,000 39,000 D
Loading xslF345X05/form4-12212024_011230.xml…